Trial
NCT01405742
Hemophilia Adult Prophylaxis Study: Factor VIII in Severe Hemophilia A
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Pittsburgh
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Severe Hemophilia A
Intervention
rF.VIII
Why stopped
study was non-feasible per DSMB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-07